Section Arrow
Quote
ICU.NASDAQ
- SeaStar Medical Holding Corp
(Financial Status)
Quotes are at least 15-min delayed:2025/06/06 01:28 EDT
Last
 1.192
-0.018 (-1.49%)
Day High 
1.21 
Prev. Close
1.21 
1-M High
1.3399 
Volume 
91.24K 
Bid
1.18
Ask
1.21
Day Low
1.1745 
Open
1.21 
1-M Low
1.12 
Market Cap 
12.82M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.22 
20-SMA 1.23 
50-SMA 1.35 
52-W High 13.8472 
52-W Low 1.11 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.34/--
Enterprise Value
17.15M
Balance Sheet
Book Value Per Share
0.05
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
135.00K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NCNANuCana plc0.0393-0.0068-14.75%-- 
CLRBCellectar Biosciences0.399201-0.062499-13.54%-- 
RXRXRecursion Pharmaceuticals4.56-0.35-7.13%-- 
GLYCGlycoMimetics0.1994-0.0106-5.05%-- 
SCNIScinai Immunotherapeutics Ltd.3.07+0.55+21.83%1.21PE
Quotes are at least 15-min delayed：2025/06/06 01:28 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.